Three other leading vaccine candidates developed by AstraZeneca with Oxford University, Johnson & Johnson, and Novavax, all have used aborted fetal cell lines both in production and in testing. All three candidates are still in Phase III trials.
Yes, that’s false (but true forAstraZeneca and J&J).
The Novavax antigens are produced in moth cells and this article states very directly that fetal cells weren’t used at all, including in testing.